Perımenopausal Women's Attıtudes Towards Menopause and Spırıtual Well-Beıng
Launched by SINOP UNIVERSITY · Dec 10, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study will be carried out as a pre-test - post-test randomized controlled experimental study. The population of the research consists of female patients between the ages of 45-55 who are registered to a family health center located in a provincial center in the north of Turkey. Women who are in the perimenopausal period and meet the inclusion criteria according to the Staging of Reproductive Aging in Women (STRAW) criteria will be included in the study. The random.org program will be used to unbiasedly assign 60 women who meet the research criteria to the experimental and control group...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Being in the perimenopausal period
- • Being between the ages of 40-55
- • Having entered menopause naturally
- • Volunteering to participate in research
- Exclusion Criteria:
- • Having a physical problem that prevents exercise
- • Being on hormone therapy
- • Not having a menstrual period for more than 8 months
- • Not using a smartphone
About Sinop University
Sinop University is a reputable academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medical sciences to conduct rigorous studies aimed at improving patient outcomes. Sinop University is committed to adhering to ethical standards and regulatory guidelines, ensuring the integrity and reliability of its clinical research initiatives. By fostering partnerships with healthcare providers and industry stakeholders, the university aims to translate its findings into practical applications that enhance public health and contribute to the scientific community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sinop, , Turkey
Patients applied
Trial Officials
Aynur ATAMAN KUFACI
Principal Investigator
Sinop University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported